May 14, 2019 / 08:40PM GMT
Tazeen Ahmad - BofA Merrill Lynch, Research Division - VP
Good afternoon. I'm Tazeen Ahmad. I'm the Senior SMID Biotech Analyst here at Bank of America Merrill Lynch. It's my pleasure to introduce our next presenting company at our healthcare conference, PTC Therapeutics. Sitting next to me from PTC is Marcio Souza, who's the Chief Operating Officer. We are happy to have you. And maybe you can start off for those people in the audience who may not be as familiar with PTC about a 2-minute introduction of the company.
Marcio Souza - PTC Therapeutics, Inc. - COO
I'll do it in 30 seconds.
Tazeen Ahmad - BofA Merrill Lynch, Research Division - VP
Or a 1-minute introduction about what the current updates -- most recent updates have been, what you focus on and what we could look forward to. And then we'll go from there.
Marcio Souza - PTC Therapeutics, Inc. - COO
Yes. And thanks, Tazeen. Thanks for all of you, and pleasure being here. And I'm sorry, I'm just telling Tazeen I'm
PTC Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
